# Werfen Launches QUANTA   Link® 5.0: A Modern, Web-Based Platform for Autoimmune Laboratory Workflow Management

- Link: https://www.thailand-business-news.com/pr-news/werfen-launches-quanta-link-5-0-a-modern-web-based-platform-for-autoimmune-laboratory-workflow-management
- Published: 2026-10-06T19:00:00+07:00
- Author: PR Newswire

_A flexible, browser-based solution, QUANTA Link 5.0 centralizes autoimmune testing
workflows. It enhances usability, streamlines workflows, and supports confident 
decision-making in today’s autoimmune laboratories._

SAN DIEGO, Oct. 6, 2026 /PRNewswire/ — Werfen today announced the global launch 
of **QUANTA Link 5.0**, a major advancement in its data management platform for 
autoimmune laboratories. The new version introduces a browser-based solution designed
to simplify daily operations, improve workflow visibility, and support laboratories
in managing increasing testing complexity with greater efficiency and confidence.

[⌊QUANTA Link 5.0: A browser-based data management system for autoimmune laboratories⌉⌊
QUANTA Link 5.0: A browser-based data management system for autoimmune laboratories⌉[
QUANTA Link
5.0: A browser-based data management system for autoimmune laboratories

At the core of QUANTA Link 5.0 is a transition to an HTML-based interface, enabling
laboratories to access through a standard web browser. This approach delivers a 
more intuitive, consistent user experience while allowing greater flexibility in
how and where users interact with the platform—without requiring local installations.

As laboratories increasingly prioritize digitalization, IT alignment, and cybersecurity
readiness, QUANTA Link 5.0 supports these evolving needs through:

 ◦ A modern web-based interface that streamlines workflows and improves navigation
   across workstations
 ◦ Enhanced order management and usability, with consolidated views that integrate
   patient history, prior results, and contextual insights for faster review
 ◦ Improved result visualization and analytics to track workflow status, monitor
   trends, and support consistent interpretation
 ◦ Expanded traceability, audit, and security controls to strengthen compliance 
   and transparency
 ◦ A scalable architecture with improved performance and configurability to support
   evolving laboratory operations and future innovation

QUANTA Link 5.0 preserves validated workflows, ensuring continuity, reliable instrument
integration, and seamless LIS connectivity for current users. Additional enhancements,
including increased automation and standardized workflows, reduce manual steps and
improve efficiency in high-volume environments. Flexible configuration options enable
laboratories to adapt the system to their specific needs.

"QUANTA Link 5.0 reflects our commitment to delivering solutions that are both powerful
and easy to use in real-world autoimmune laboratory settings," said Vijay Namasivayam,
PhD, Chief Operating Officer, Autoimmunity. "By combining a modern, flexible user
experience with meaningful workflow improvements, we are helping laboratories operate
more efficiently while continuing to support clinicians in delivering high-quality
patient care."

**About QUANTA Link**

QUANTA Link is Werfen’s data management platform that centralizes autoimmune testing
workflows by integrating results from Aptiva^(®), BIO‑FLASH^(®), QUANTA‑Lyser^(®)
3000, NOVA View^(®), and manual microscopy into a single, unified interface. It 
streamlines result handling, enhances traceability, and supports consistent data
interpretation across laboratory operations.

**QUANTA Link 5.0 is available now to Werfen customers worldwide.**

**About Werfen**

Werfen ([werfen.com](https://edge.prnewswire.com/c/link/?t=0&l=en&o=4789525-1&h=1270629617&u=http%3A%2F%2Fwww.werfen.com%2F&a=werfen.com))
founded in 1966, is a worldwide developer, manufacturer and distributor of specialized
diagnostic instruments, related reagents, automation workcells, and data management
solutions for use primarily in hospitals and independent clinical laboratories. 
The Company’s clinical areas of focus include Autoimmunity, Hemostasis, Acute Care
Diagnostics, Transfusion, and Transplant. 

Werfen’s solutions help improve the way patients with autoimmune diseases are diagnosed,
monitored, and treated. The autoimmunity portfolio includes Aptiva^(®), BIO-FLASH
^(®), NOVA View^(®), and QUANTA-Lyser^(®) 3000 systems, and QUANTA Link^(®) data
management solution.

The Werfen logo is a trademark of Werfen. Aptiva, QUANTA-Lyser, QUANTA Lite, QUANTA
Link, QUANTA Flash, NOVA View, NOVA Lite are registered trademarks of Inova Diagnostics,
Inc., a Werfen company. BIO-FLASH is a registered trademark of Biokit S.A. All other
product names, company names, marks, logos, and symbols are trademarks of their 
respective owners.

---

  |  This article was produced by Cision PR Newswire, our trusted news partner. The views expressed and the content presented here are solely those of the author and may not fully reflect the opinions of Thailand Business News. |

---

 
**Read the original article :** [Werfen Launches QUANTA Link® 5.0: A Modern, Web-Based Platform for Autoimmune Laboratory Workflow Management ](http://www.prnasia.com/story/archive/5063691_AE63691_0?rand=184833)